Refractory vaccines adopt COVID antibody treatment, mystifying doctors



[ad_1]

Lanson Jones, Houston.

Howard Huang, MD, pulmonologist, Houston Methodist Hospital.

Amesh Adalja, MD, Emerging Infectious Disease Specialist, Johns Hopkins University Center for Health Security.

Terry Scoggin, CEO, Titus Regional Medical Center, Mount Pleasant, Texas.

Frederick Thurmond, MD, hospitalist, Titus Regional Medical Center.

Seth Thurman, Mount Pleasant, Texas.

Whitehouse.gov: “President Biden’s remarks on tackling the COVID-19 pandemic. “

The New York Times: “See how the vaccinations are going in your county and state”, “They avoided the Covid vaccines but adopted the antibody treatment. “

CDC: “COVID-19 Vaccinations in the United States. “

Infectious Diseases Society of America: “Immunomodulators”.

The
New England Journal of Medicine: “Combination of subcutaneous REGEN-COV antibodies to prevent Covid-19.”

American scientist: “Do Monoclonal Antibodies Help COVID Patients?”

Medincinenet.com: “Monoclonal Antibodies: Uses, Types, Side Effects and COVID-19”.



[ad_2]

Source link